Neuren Pharmaceuticals | NEU - Umlaufvermögen

Aktienkurs
12.33
Täglich Wechseln
0.15 1.23%
Monatlich
3.35%
Jährlich
12.19%
Q2 Prognose
12.10




Umlaufvermögen Veränderung Datum
Akebia Therapeutics USD 252.96M 5.38M 2025-12
Alaunos Therapeutics USD 2.68M 1.05M 2025-09
Avita Medical AUD 35.49M 760K 2025-12
Clinuvel Pharmaceuticals AUD 261.38M 1.59M 2025-12
Dianthus Therapeutics USD 409.44M 4.39M 2025-12
Genetic Signatures AUD 42.96M 5.02M 2025-12
Ionis Pharmaceuticals USD 2.99B 471.01M 2025-12
Medical Developments International AUD 33.75M 1.79M 2025-12
Neuren Pharmaceuticals AUD 332.23M 11.98M 2025-12
Organon & Co USD 4.7B 82M 2025-09
Paradigm Biopharmaceuticals AUD 21.67M 2.46M 2025-12
PYC Therapeutics AUD 153.74M 23.79M 2025-12
Starpharma Holdings AUD 24.24M 1.68M 2025-12
Tectonic Therapeutic USD 257.36M 15.88M 2025-12
Telix Pharmaceuticals AUD 330.28M 67.73M 2025-12
Viatris USD 9.79B 162.2M 2025-12
Xeris Pharmaceuticals USD 240.31M 16.3M 2025-12